Dr. Michael Chu, MD
Claim this profileLondon Health Sciences Centre
Studies Mitral Regurgitation
Studies Mitral Valve Regurgitation
17 reported clinical trials
26 drugs studied
Affiliated Hospitals
Clinical Trials Michael Chu, MD is currently running
TAVR
for Aortic Stenosis
Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.
Recruiting1 award N/A3 criteria
Left Atrial Appendage Exclusion
for Stroke Prevention
This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.
Recruiting1 award N/A2 criteria
More about Michael Chu, MD
Clinical Trial Related3 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Michael Chu, MD has experience with
- Autologous CD19-directed Chimeric Antigen Receptor (CAR) T-cells
- Model 400 Aortic Valve Bioprosthesis
- Thoracic Aortic Surgery
- Mitral Repair With Leaflet Preservation
- Mitral Repair With Leaflet Resection
- Hypothermic Circulatory Arrest
Breakdown of trials Michael Chu, MD has run
Mitral Regurgitation
Mitral Valve Regurgitation
Stroke
Coronary Artery Disease
Aortic Valve Stenosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Chu, MD specialize in?
Michael Chu, MD focuses on Mitral Regurgitation and Mitral Valve Regurgitation. In particular, much of their work with Mitral Regurgitation has involved treating patients, or patients who are undergoing treatment.
Is Michael Chu, MD currently recruiting for clinical trials?
Yes, Michael Chu, MD is currently recruiting for 10 clinical trials in London Ontario. If you're interested in participating, you should apply.
Are there any treatments that Michael Chu, MD has studied deeply?
Yes, Michael Chu, MD has studied treatments such as autologous CD19-directed chimeric antigen receptor (CAR) T-cells, Model 400 Aortic Valve Bioprosthesis, Thoracic Aortic Surgery.
What is the best way to schedule an appointment with Michael Chu, MD?
Apply for one of the trials that Michael Chu, MD is conducting.
What is the office address of Michael Chu, MD?
The office of Michael Chu, MD is located at: London Health Sciences Centre, London, Ontario N6A 5A5 Canada. This is the address for their practice at the London Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.